Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

NCT00904280 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancers, Pain
Lower Back Pain

Interventions

DRUG: Oxymorphone ER

Sponsor

Endo Pharmaceuticals